Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
PMID 39728000
Still, it is clear that GLP-1 new drug treatments like tirzepatide (sold as Mounjaro for diabetes and ZepBound for obesity by Eli Lilly, and as Mounjaro/ZepBound for weight management) and semaglutide (Wegovy/Ozempic by Novo Nordisk) are among the fastest-growing and highest-earning drugs on the planet
The glucagon arm appears to contribute substantively to body-composition outcomes (favouring fat-mass reduction) without offsetting the glycemic outcomes of the GLP-1/GIP arms (PMID 39515565, PMID 40609566)
Weight Loss Care, Personalized to You Connect with a provider who can help determine whether GLP-1 treatment is right for you, then get ongoing support to stay on track
